Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tgf tgf bcr abl'

Search results for: 'research area tgf tgf bcr abl'

Items 1-10 of 27

Page
per page
  1. LY2109761
    A8464 LY2109761
     4 Citation
    Summary: TβRI/II kinase inhibitor
      ≥22.1 mg/mL
  2. LY2157299
    A8348 LY2157299
     2 Citation
    Summary: TGF-βR1 inhibitor,potent and selective
      insoluble in H2O; ≥18.45 mg/mL
  3. GW788388
    A8301 GW788388
    Summary: ALK5 inhibitor,potent and selective
      ≥21.25 mg/mL
  4. A 83-01
    A3133 A 83-01
    Summary: ALK-5 inhibitor
      ≥21.1 mg/mL
  5. Nilotinib(AMN-107)
    A8232 Nilotinib(AMN-107)
     1 Citation
    Target: Bcr-Abl
    Summary: Bcr-Abl kinase inhibitor,selective
      ≥26.5 mg/mL
  6. SB 431542
    A8249 SB 431542
     2 Citation
    Summary: ALK inhibitor
  7. Enzastaurin (LY317615)
    A1670 Enzastaurin (LY317615)
     2 Citation
    Target: PKC
    Summary: PKC beta inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL
  8. (-)-Epigallocatechin gallate (EGCG)
    A2600 (-)-Epigallocatechin gallate (EGCG)
    Target: BACE
    Summary: Antioxidant, antiangiogenic and antitumor agent
      ≥22.9 mg/mL
  9. Bosutinib (SKI-606)
    A2149 Bosutinib (SKI-606)
     1 Citation
    Target: Bcr-Abl|Src
    Summary: Potent Abl/Src kinases
      ≥26.5 mg/mL
  10. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL

Items 1-10 of 27

Page
per page